Team2024-03-04T16:31:50+00:00Biden EO Places More Controls on Chinese Genomics CompaniesTeam2024-03-04T16:31:50+00:0003/01/2024|
Team2024-07-08T21:05:38+00:00United Antitrust Investigation Will Take TimeTeam2024-07-08T21:05:38+00:0002/29/2024|
Team2024-02-26T19:01:49+00:00Healthcare (Still) Likely Minimal in CRTeam2024-02-26T19:01:49+00:0002/26/2024|
Team2024-02-26T15:26:12+00:00A Closer Look at South Carolina ResultsTeam2024-02-26T15:26:12+00:0002/25/2024|
Team2024-02-24T17:56:05+00:00CO Seeks Upper Payment Limit for EnbrelTeam2024-02-24T17:56:05+00:0002/23/2024|
Team2024-02-24T17:56:25+00:00Healthcare Likely Minimal in March CRTeam2024-02-24T17:56:25+00:0002/21/2024|
Team2024-07-08T21:37:46+00:00PhRMA Negotiation Lawsuit Dismissed in TX CourtTeam2024-07-08T21:37:46+00:0002/13/2024|
Team2024-02-12T17:07:25+00:00Pill Penalty Fix Bill (9-to-13) Unlikely to PassTeam2024-02-12T17:07:25+00:0002/06/2024|
Team2024-02-01T20:05:33+00:00CMS Price Offers Going Out As R&D Expensing Bipartisan Vote Takes Place TonightTeam2024-02-01T20:05:33+00:0001/31/2024|
Team2024-02-01T19:53:30+00:00MA Rates: -0.16% Without Risk Score GrowthTeam2024-02-01T19:53:30+00:0001/31/2024|
Team2024-02-01T20:17:52+00:00Cell & Gene Therapy CMS Model Prioritizes Sickle CellTeam2024-02-01T20:17:52+00:0001/30/2024|
